Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Testicular involvement without testicular enlargement in a young male with atypical chronic myeloid leukemia.

Shima H, Ito J, Isshiki K, Sekinaka Y, Yamazaki F, Shimada H.

Pediatr Blood Cancer. 2019 Jul 5:e27911. doi: 10.1002/pbc.27911. [Epub ahead of print] No abstract available.

PMID:
31276287
2.

Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013-18.

Shinjoh M, Sugaya N, Furuichi M, Araki E, Maeda N, Isshiki K, Ohnishi T, Nakamura S, Yamada G, Narabayashi A, Nishida M, Taguchi N, Nakata Y, Yoshida M, Tsunematsu K, Shibata M, Munenaga T, Hirano Y, Ookawara I, Sekiguchi S, Kobayashi Y, Yamaguchi Y, Yoshida N, Mitamura K, Takahashi T; Keio Pediatric Influenza Research Group.

Vaccine. 2019 Jul 9;37(30):4047-4054. doi: 10.1016/j.vaccine.2019.05.090. Epub 2019 Jun 8.

PMID:
31186191
3.

Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging.

Takahashi N, Yamada Y, Hoshino K, Kawaida M, Mori T, Abe K, Fujimura T, Matsubara K, Hibi T, Shinoda M, Obara H, Isshiki K, Shima H, Shimada H, Kameyama K, Fuchimoto Y, Kitagawa Y, Kuroda T.

Cancers (Basel). 2019 May 26;11(5). pii: E730. doi: 10.3390/cancers11050730.

4.

Intracellular localization and binding partners of death associated protein kinase-related apoptosis-inducing protein kinase 1.

Oue Y, Murakami S, Isshiki K, Tsuji A, Yuasa K.

Biochem Biophys Res Commun. 2018 Feb 19;496(4):1222-1228. doi: 10.1016/j.bbrc.2018.01.175. Epub 2018 Jan 31.

PMID:
29397938
5.

Overexpression of acetyl CoA carboxylase β exacerbates podocyte injury in the kidney of streptozotocin-induced diabetic mice.

Tanaka Y, Kume S, Maeda S, Osawa N, Takeda N, Chin-Kanasaki M, Isshiki K, Ugi S, Oshima I, Uzu T, Maegawa H, Araki SI.

Biochem Biophys Res Commun. 2018 Jan 1;495(1):1115-1121. doi: 10.1016/j.bbrc.2017.11.145. Epub 2017 Nov 23.

PMID:
29175208
6.

Successful haploidentical BMT with post-transplant cyclophosphamide for refractory autoimmune pancytopenia after cord blood transplant in pediatric myelodysplastic syndrome.

Shima H, Isshiki K, Yamada Y, Yamazaki F, Takahashi T, Shimada H.

Bone Marrow Transplant. 2017 Apr;52(4):653-655. doi: 10.1038/bmt.2016.341. Epub 2017 Jan 9. No abstract available.

PMID:
28067878
7.

Death-associated protein kinase 2 mediates nocodazole-induced apoptosis through interaction with tubulin.

Isshiki K, Hirase T, Matsuda S, Miyamoto K, Tsuji A, Yuasa K.

Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):113-8. doi: 10.1016/j.bbrc.2015.10.151. Epub 2015 Oct 31.

PMID:
26529546
8.

Focal Segmental Glomerular Sclerosis Ameliorated by Long-term Hemodialysis Therapy with Low-density Lipoprotein Apheresis.

Araki H, Ono S, Nishizawa Y, Deji N, Nakazawa J, Morita Y, Kume S, Chin-Kanasaki M, Isshiki K, Araki S, Arimura T, Maegawa H, Uzu T.

Intern Med. 2015;54(17):2213-7. doi: 10.2169/internalmedicine.54.4631. Epub 2015 Sep 1.

9.

Suppression of death-associated protein kinase 2 by interaction with 14-3-3 proteins.

Yuasa K, Ota R, Matsuda S, Isshiki K, Inoue M, Tsuji A.

Biochem Biophys Res Commun. 2015 Aug 14;464(1):70-5. doi: 10.1016/j.bbrc.2015.05.105. Epub 2015 Jun 3.

PMID:
26047703
10.

Oral glucose-stimulated serum C-peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment.

Araki H, Tanaka Y, Yoshida S, Morita Y, Kume S, Isshiki K, Araki S, Uzu T, Kashiwagi A, Maegawa H.

J Diabetes Investig. 2014 Jul;5(4):435-41. doi: 10.1111/jdi.12169. Epub 2013 Nov 28.

11.

Predictive properties of plasma amino acid profile for cardiovascular disease in patients with type 2 diabetes.

Kume S, Araki S, Ono N, Shinhara A, Muramatsu T, Araki H, Isshiki K, Nakamura K, Miyano H, Koya D, Haneda M, Ugi S, Kawai H, Kashiwagi A, Uzu T, Maegawa H.

PLoS One. 2014 Jun 27;9(6):e101219. doi: 10.1371/journal.pone.0101219. eCollection 2014.

12.

PCTAIRE kinase 3/cyclin-dependent kinase 18 is activated through association with cyclin A and/or phosphorylation by protein kinase A.

Matsuda S, Kominato K, Koide-Yoshida S, Miyamoto K, Isshiki K, Tsuji A, Yuasa K.

J Biol Chem. 2014 Jun 27;289(26):18387-400. doi: 10.1074/jbc.M113.542936. Epub 2014 May 15.

13.

Fatty acids are novel nutrient factors to regulate mTORC1 lysosomal localization and apoptosis in podocytes.

Yasuda M, Tanaka Y, Kume S, Morita Y, Chin-Kanasaki M, Araki H, Isshiki K, Araki S, Koya D, Haneda M, Kashiwagi A, Maegawa H, Uzu T.

Biochim Biophys Acta. 2014 Jul;1842(7):1097-108. doi: 10.1016/j.bbadis.2014.04.001. Epub 2014 Apr 13.

14.

Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.

Isshiki K, Nishio T, Isono M, Makiishi T, Shikano T, Tomita K, Nishio T, Kanasaki M, Maegawa H, Uzu T; Lake Biwa Clinical Dialysis Meeting.

Ther Apher Dial. 2014 Oct;18(5):434-42. doi: 10.1111/1744-9987.12123. Epub 2013 Nov 20.

PMID:
24251784
15.

How do chondrocytes aggregate on fibroin substrate.

Otaka A, Takahashi K, Isshiki K, Kambe Y, Kojima K, Tamada Y, Tomita N.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:405-8. doi: 10.1109/EMBC.2013.6609522.

PMID:
24109709
16.

Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions.

Yamahara K, Kume S, Koya D, Tanaka Y, Morita Y, Chin-Kanasaki M, Araki H, Isshiki K, Araki S, Haneda M, Matsusaka T, Kashiwagi A, Maegawa H, Uzu T.

J Am Soc Nephrol. 2013 Nov;24(11):1769-81. doi: 10.1681/ASN.2012111080. Epub 2013 Oct 3.

17.

Safety and efficacy of skin patches containing loxoprofen sodium in diabetic patients with overt nephropathy.

Araki H, Kuwagata S, Soumura M, Yamahara K, Morita Y, Kume S, Isshiki K, Araki S, Kashiwagi A, Maegawa H, Uzu T.

Clin Exp Nephrol. 2014 Jun;18(3):487-91. doi: 10.1007/s10157-013-0850-4. Epub 2013 Aug 7.

18.

Altered unfolded protein response is implicated in the age-related exacerbation of proteinuria-induced proximal tubular cell damage.

Takeda N, Kume S, Tanaka Y, Morita Y, Chin-Kanasaki M, Araki H, Isshiki K, Araki S, Haneda M, Koya D, Kashiwagi A, Maegawa H, Uzu T.

Am J Pathol. 2013 Sep;183(3):774-85. doi: 10.1016/j.ajpath.2013.05.026. Epub 2013 Jul 17.

PMID:
23871833
19.

Cilostazol attenuates spontaneous microaggregation of platelets in type 2 diabetic patients with insufficient platelet response to aspirin.

Araki S, Matsuno H, Haneda M, Koya D, Kanno Y, Kume S, Isshiki K, Araki H, Ugi S, Kawai H, Kashiwagi A, Uzu T, Maegawa H.

Diabetes Care. 2013 Jul;36(7):e92-3. doi: 10.2337/dc12-2702. No abstract available.

20.

Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy.

Araki S, Haneda M, Koya D, Sugaya T, Isshiki K, Kume S, Kashiwagi A, Uzu T, Maegawa H.

Diabetes Care. 2013 May;36(5):1248-53. doi: 10.2337/dc12-1298. Epub 2012 Dec 5.

21.

Engineering of α1-antitrypsin variants with improved specificity for the proprotein convertase furin using site-directed random mutagenesis.

Hada K, Isshiki K, Matsuda S, Yuasa K, Tsuji A.

Protein Eng Des Sel. 2013 Feb;26(2):123-31. doi: 10.1093/protein/gzs091. Epub 2012 Nov 14.

PMID:
23155057
22.

High sodium intake is associated with masked hypertension in Japanese patients with type 2 diabetes and treated hypertension.

Uzu T, Nakao K, Kume S, Araki H, Isshiki K, Araki S, Kawai H, Ugi S, Kashiwagi A, Maegawa H.

Am J Hypertens. 2012 Nov;25(11):1170-4. doi: 10.1038/ajh.2012.102. Epub 2012 Jul 19.

PMID:
22810841
23.

Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis.

Kume S, Uzu T, Takagi C, Kondo M, Okabe T, Araki S, Isshiki K, Takeda N, Kondo K, Haneda M, Koya D, Nishio Y, Kashiwagi A, Maegawa H.

J Diabetes Investig. 2012 Jun 6;3(3):298-301. doi: 10.1111/j.2040-1124.2011.00169.x.

24.

cGMP-dependent protein kinase I promotes cell apoptosis through hyperactivation of death-associated protein kinase 2.

Isshiki K, Matsuda S, Tsuji A, Yuasa K.

Biochem Biophys Res Commun. 2012 Jun 1;422(2):280-4. doi: 10.1016/j.bbrc.2012.04.148. Epub 2012 May 3.

PMID:
22580283
25.

Yersiniosis and food safety.

Bari L, Ukuku DO, Isshiki K, Ray RC, Montet D.

J Pathog. 2012;2012:605037. doi: 10.1155/2012/605037. Epub 2012 Mar 20. No abstract available.

26.

Fructose induces tubulointerstitial injury in the kidney of mice.

Aoyama M, Isshiki K, Kume S, Chin-Kanasaki M, Araki H, Araki S, Koya D, Haneda M, Kashiwagi A, Maegawa H, Uzu T.

Biochem Biophys Res Commun. 2012 Mar 9;419(2):244-9. doi: 10.1016/j.bbrc.2012.02.001. Epub 2012 Feb 8.

PMID:
22342673
27.

Arterial stiffness and renal impairment in non-proteinuric type 2 diabetic patients.

Nakao K, Uzu T, Araki S, Kume S, Deji N, Chin-Kanasaki M, Araki H, Isshiki K, Sugimoto T, Kawai H, Nishio Y, Kashiwagi A, Maegawa H.

J Diabetes Investig. 2012 Feb 20;3(1):86-91. doi: 10.1111/j.2040-1124.2011.00146.x.

28.

Role of angiotensin II-mediated AMPK inactivation on obesity-related salt-sensitive hypertension.

Deji N, Kume S, Araki S, Isshiki K, Araki H, Chin-Kanasaki M, Tanaka Y, Nishiyama A, Koya D, Haneda M, Kashiwagi A, Maegawa H, Uzu T.

Biochem Biophys Res Commun. 2012 Feb 17;418(3):559-64. doi: 10.1016/j.bbrc.2012.01.070. Epub 2012 Jan 24.

PMID:
22293193
29.
30.

[Control of halophilic histamine-producing bacteria by using natural antimicrobials and other agents].

Kamii E, Terada G, Akiyama J, Isshiki K.

Shokuhin Eiseigaku Zasshi. 2011;52(6):315-20. Japanese.

31.

[Antibacterial activity of essential oil vapor for histamine-producing bacteria].

Kamii E, Terada G, Akiyama J, Isshiki K.

Shokuhin Eiseigaku Zasshi. 2011;52(5):276-80. Japanese.

32.

[Inhibitory effect of essential oils, food additives, peracetic acid and detergents on bacterial histidine decarboxylase].

Kamii E, Terada G, Akiyama J, Isshiki K.

Shokuhin Eiseigaku Zasshi. 2011;52(5):271-5. Japanese.

33.

The effects of blood pressure control levels on the renoprotection of type 2 diabetic patients without overt proteinuria.

Uzu T, Kida Y, Yamauchi A, Kume S, Isshiki K, Araki S, Koya D, Haneda M, Kashiwagi A, Maegawa H, Kikkawa R.

J Am Soc Hypertens. 2012 Mar-Apr;6(2):124-31. doi: 10.1016/j.jash.2011.11.001. Epub 2011 Dec 22.

PMID:
22197317
34.

GW501516, a PPARδ agonist, ameliorates tubulointerstitial inflammation in proteinuric kidney disease via inhibition of TAK1-NFκB pathway in mice.

Yang X, Kume S, Tanaka Y, Isshiki K, Araki S, Chin-Kanasaki M, Sugimoto T, Koya D, Haneda M, Sugaya T, Li D, Han P, Nishio Y, Kashiwagi A, Maegawa H, Uzu T.

PLoS One. 2011;6(9):e25271. doi: 10.1371/journal.pone.0025271. Epub 2011 Sep 22.

35.

Furosemide-associated nephrocalcinosis and renal cysts.

Uzu T, Araki S, Isshiki K, Maegawa H.

Kidney Int. 2011 Sep;80(5):556. doi: 10.1038/ki.2011.186. No abstract available.

36.

SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells.

Koyama T, Kume S, Koya D, Araki S, Isshiki K, Chin-Kanasaki M, Sugimoto T, Haneda M, Sugaya T, Kashiwagi A, Maegawa H, Uzu T.

Free Radic Biol Med. 2011 Sep 15;51(6):1258-67. doi: 10.1016/j.freeradbiomed.2011.05.028. Epub 2011 May 30.

PMID:
21664458
37.

A dialysis patient with hyperammonaemia: inferior mesenteric-caval shunt as a cause of portal-systemic encephalopathy.

Izumiya-Iwai T, Isshiki K, Chin-Kanasaki M, Uzu T.

NDT Plus. 2011 Jun;4(3):221-2. doi: 10.1093/ndtplus/sfr039. No abstract available.

38.

[Food protective property of new liquid food container PID (Pouch in Dispenser) for microbes].

Tominari K, Tanaka A, Shinoda Y, Futase K, Nei D, Isshiki K.

Shokuhin Eiseigaku Zasshi. 2011;52(2):108-11. Japanese.

39.

Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis.

Tanaka Y, Kume S, Araki S, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Sugimoto T, Koya D, Haneda M, Kashiwagi A, Maegawa H, Uzu T.

Kidney Int. 2011 Apr;79(8):871-82. doi: 10.1038/ki.2010.530. Epub 2011 Jan 26.

40.

Successful renal replacement therapy for a patient with severe hemophilia after surgical treatment of intracranial hemorrhage and hydrocephalus.

Kato N, Chin-Kanasaki M, Tanaka Y, Yasuda M, Yokomaku Y, Sakaguchi M, Isshiki K, Araki S, Ohta S, Uzu T.

Case Rep Nephrol. 2011;2011:824709. doi: 10.1155/2011/824709. Epub 2011 Nov 17.

41.

Behavior of Yersinia enterocolitica in Foods.

Bari ML, Hossain MA, Isshiki K, Ukuku D.

J Pathog. 2011;2011:420732. doi: 10.4061/2011/420732. Epub 2011 Oct 23.

42.

Effects of blood pressure and the renin-angiotensin system on platelet activation in type 2 diabetes.

Uzu T, Sakaguchi M, Tsuda A, Kadota A, Yokomaku Y, Kume S, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Maegawa H, Kashiwagi A.

J Diabetes Investig. 2010 Oct 19;1(5):196-201. doi: 10.1111/j.2040-1124.2010.00048.x.

43.

Oleate and eicosapentaenoic acid attenuate palmitate-induced inflammation and apoptosis in renal proximal tubular cell.

Soumura M, Kume S, Isshiki K, Takeda N, Araki S, Tanaka Y, Sugimoto T, Chin-Kanasaki M, Nishio Y, Haneda M, Koya D, Kashiwagi A, Maegawa H, Uzu T.

Biochem Biophys Res Commun. 2010 Nov 12;402(2):265-71. doi: 10.1016/j.bbrc.2010.10.012. Epub 2010 Oct 16.

PMID:
20937260
44.

The effects of single nucleotide polymorphisms in CYP2A13 on metabolism of 5-methoxypsoralen.

Goto T, Moriuchi H, Fu X, Ikegawa T, Matsubara T, Chang G, Uno T, Morigaki K, Isshiki K, Imaishi H.

Drug Metab Dispos. 2010 Dec;38(12):2110-6. doi: 10.1124/dmd.110.034553. Epub 2010 Aug 26.

PMID:
20798279
45.

Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria.

Araki S, Haneda M, Koya D, Isshiki K, Kume S, Sugimoto T, Kawai H, Nishio Y, Kashiwagi A, Uzu T, Maegawa H.

Diabetes Care. 2010 Aug;33(8):1805-10. doi: 10.2337/dc10-0199.

46.

Renoprotective effects of asialoerythropoietin in diabetic mice against ischaemia-reperfusion-induced acute kidney injury.

Nakazawa J, Isshiki K, Sugimoto T, Araki S, Kume S, Yokomaku Y, Chin-Kanasaki M, Sakaguchi M, Koya D, Haneda M, Kashiwagi A, Uzu T.

Nephrology (Carlton). 2010 Feb;15(1):93-101. doi: 10.1111/j.1440-1797.2009.01170.x.

PMID:
20377776
47.

Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney.

Kume S, Uzu T, Horiike K, Chin-Kanasaki M, Isshiki K, Araki S, Sugimoto T, Haneda M, Kashiwagi A, Koya D.

J Clin Invest. 2010 Apr;120(4):1043-55. doi: 10.1172/JCI41376. Epub 2010 Mar 24.

48.

Cerebral microvascular disease predicts renal failure in type 2 diabetes.

Uzu T, Kida Y, Shirahashi N, Harada T, Yamauchi A, Nomura M, Isshiki K, Araki S, Sugimoto T, Koya D, Haneda M, Kashiwagi A, Kikkawa R.

J Am Soc Nephrol. 2010 Mar;21(3):520-6. doi: 10.1681/ASN.2009050558. Epub 2010 Jan 28.

49.

[Antimicrobial efficacy of benzyl isothiocyanate].

Kamii E, Isshiki K.

Shokuhin Eiseigaku Zasshi. 2009 Dec;50(6):311-4. Japanese.

50.

Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients.

Araki S, Matsuno H, Haneda M, Koya D, Kanno Y, Itho J, Kishi A, Isshiki K, Sugimoto T, Maegawa H, Kashiwagi A, Uzu T.

Diabetes Care. 2009 Nov;32(11):2062-7. doi: 10.2337/dc09-0584. Epub 2009 Aug 12.

Supplemental Content

Loading ...
Support Center